Skip to content

Comparing benzoin resin and Coe-Pak for gum healing after pigmentation removal surgery

Benzoin resin tincture versus Coe-Pak for postoperative healing after gingival depigmentation: a randomized controlled split-mouth clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69063431
Enrollment
12
Registered
2025-08-08
Start date
2024-06-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiological gingival pigmentation Postoperative healing after depigmentation surgery Oral Health

Interventions

Healthy adult participants aged 18–40 years with bilateral physiological gingival pigmentation in the upper anterior region were enrolled after providing written informed consent. Each participant und

Sponsors

Damascus University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18–40 years 2. Presence of physiological melanin pigmentation in the upper anterior gingiva (Hedin index 3 or 4) 3. Confirmed absence of systemic or pathological causes of pigmentation 4. Good general health (ASA I) 5. Adequate width and thickness of attached gingiva 6. No signs of active periodontal disease 7. No prior surgical intervention in the target area 8. Informed consent provided and willingness to comply with follow-up visits

Exclusion criteria

Exclusion criteria: 1. Smoking or tobacco use 2. Alcohol abuse 3. Pregnancy or lactation 4. Use of anti-inflammatory, immunosuppressive, or photosensitizing medications 5. Systemic diseases affecting healing (e.g. uncontrolled diabetes) 6. History of radiation therapy 7. Known allergy to any component of benzoin resin tincture or Coe-Pak dressing

Design outcomes

Primary

MeasureTime frame
Epithelialization index measured using the degree of epithelial coverage at the surgical site (Grade 0–3), weekly for 4 weeks postoperatively

Secondary

MeasureTime frame
1. Healing measured using the Wound Healing Index (H1–H5) assessed weekly for 4 weeks 2. Pain measured using a Visual Analog Scale (VAS ) daily from Day 1 to Day 7 3. Rescue medication usage measured using the number of analgesic tablets consumed over 7 days

Countries

Syria

Contacts

Public ContactTala Alkhin Alkhin
tala.alkhin98@damascusuniversity.edu.sy+963932985177

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026